NURS FPX 6021 Assessment 2 Change Strategy and Implementation NURS-FPX 6021 Biopsychosocial Concepts for Advanced Nursing Practice 1 ​​​​​​​Change Strategy and Implementation

. 

Data Table of Current and Desired Clinical Outcomes 

The data table in the appendix depicts the current and desired states of various clinical outcomes in AKI-infected patients at MedStar Washington Hospital Center. The data is collected through the organization’s dashboard and patient surveys. Compliance with the Health Insurance Portability and Accountability Act (HIPAA) is prioritized to maintain patients’ privacy and confidentially and ensure robust security measures are applied to extract the data from the organization’s information management systems (Rosenbloom et al., 2019).

However, some areas of ambiguity in the data collection process required further information to improve the analysis. These include a lack of detailed data on specific infection types and sources, unanswered questions about the factors leading to mortality, knowledge gaps on antibiotic usage and patterns of resistance, lack of information on secondary factors increasing hospital stays, and minimal information on factors contributing to patient dissatisfaction. Further information on these areas will improve the analysis and direct the change implementation process, targeting particular concerns. 

Change Strategies to Achieve Desired States

Secondary infections are commonly found in AKI patients due to the disease’s impact on individuals’ immune systems. Patients with acute kidney injury admitted to intensive care settings are 40-50% prone to developing infectious states (Peerapornratana et al., 2019). Antibiotic resistance and patient dissatisfaction are primary clinical outcomes that require prompt action through various change strategies. The strategies include the Antimicrobial Stewardship Program (ASP) and infection control practices (hand hygiene and environmental hygiene). 

The proposed change strategy is implementing an antimicrobial stewardship program to address antibiotic resistance. This initiative involves optimizing antibiotic use through appropriate drug selection, precise dose setting, and monitoring the duration of antibiotic treatment to ensure the best possible clinical outcomes are achieved to treat and prevent infection without encountering toxicity or resistance (Alawi et al., 2022). In my current workplace, the implementation of ASP includes developing guidelines for appropriate antibiotic use, conducting interprofessional training sessions, and seamlessly integrating existing workflows. Moreover, we aim to implement surveillance systems to monitor resistance patterns and foster a culture of answerable antibiotic prescribing.